In a landmark agreement that underscores the surging therapeutic potential of proximity biology, Swiss pharmaceutical giant Roche has joined forces…
Read More

In a landmark agreement that underscores the surging therapeutic potential of proximity biology, Swiss pharmaceutical giant Roche has joined forces…
Read More
Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…
Read More